Neue Ära in der Stoffwechselmedizin: Von PCOS bis Retatrutid – AD HOC NEWS
The landscape of metabolic health is undergoing a significant transformation, marked by both a shift in clinical nomenclature and the emergence of promising pharmacological interventions. As a physician, I have closely observed how our understanding of complex endocrine conditions—most notably the condition historically known as Polycystic Ovary Syndrome (PCOS)—is evolving to better reflect the multisystemic … Read more
